In 2016, the revised World Health Organization (WHO) guidelines classified this special type to a new category named high‐grade B‐cell lymphoma with rearrangements of MYC, BCL2 and BCL6. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.